HUMIRA for Moderate to Severe Hidradenitis Suppurativa (HS)

HUMIRA for Moderate to Severe Hidradenitis Suppurativa (HS)

What is HUMIRA?

HUMIRA is a prescription medicine used to reduce the signs and symptoms of moderate to severe hidradenitis suppurativa (HS) in people 12 years and older.

HUMIRA Results for Hidradenitis Suppurativa

HUMIRA was studied in over 600 adult patients like you with moderate to severe hidradenitis suppurativa in the largest clinical trial completed for HS at the time.

In clinical trials, HUMIRA was proven in many adult patients to reduce the total number of inflammatory nodules and abscesses by at least half without an increase in draining wounds or abscesses in just 3 months.*

*Individual results may vary.



reduction in inflammatory lesions



in number of abscesses



in the number of draining wounds

Lesions defined as inflammatory nodules and abscesses.  

Relative to baseline.

Common side effects of HUMIRA

Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.

Read about the Important Safety Information for HUMIRA.

Humira Complete

Start with support that’s designed around you

HUMIRA Complete gives you access to potential savings, injection training guides, and other helpful resources. Plus, you’re a phone call away from getting help with insurance coverage support.


HUMIRA Dosing for Hidradenitis Suppurativa

Your doctor will tell you which of the following doses is right for you.

Important: You must pay attention to your starting dose—it is different than your maintenance dose and is a critical part of taking HUMIRA as prescribed.§

HUMIRA is given by an injection under the skin.

Dosing for adults and adolescents aged 12-17 years who weigh 60 kg (132 lbs) and greater is 160 mg on Day 1 and 80 mg on Day 15. Starting on Day 29, the maintenance dose is either 40 mg every week or 80 mg every other week.

Dosing for adolescents aged 12-17 years who weigh 30 kg (66 lbs) to less than 60 kg (132 lbs) is 80 mg on Day 1. Starting on Day 8, the maintenance dose is 40 mg every other week.

Your first dose of HUMIRA must be given under the supervision of a health care professional. Make sure you have been shown how to inject HUMIRA before you do it yourself. Remember to keep your HUMIRA refrigerated in its original container until ready for use.

You should continue taking HUMIRA as directed by your doctor. Remember, HUMIRA is a treatment, not a cure. Your doctor can tell you if and when you should stop taking HUMIRA.

For more information, refer to the Patient Instructions for Use and the Medication Guide located inside the HUMIRA carton, and within the Full Prescribing Information. If you experience any adverse reactions or discomfort when taking HUMIRA, discuss them with your doctor right away.

§Refer to the Patient Instructions for Use to learn about the HUMIRA Pen and prefilled syringe.

First dose can be administered as 2 injections in 1 day or as 1 injection per day for 2 consecutive days.

How does HUMIRA work?

The protein TNF-alpha is believed to be part of your body’s natural processes involved in creating inflammation, and in some cases, excess inflammation. When used as prescribed, HUMIRA targets and blocks TNF-alpha, which can help reduce the skin inflammation associated with hidradenitis suppurativa.

Already prescribed HUMIRA?

HUMIRA Complete gives you helpful resources and one-to-one support.